✉news TechnologyTechnology first seen 3 d ago, last 3 d ago, peak #18
Nova Biomedical launches PAIA Titer for cell line development
Original: Nova Biomedical introduces PAIA Titer technology for earlier cell line development insights
Nova Biomedical has introduced PAIA Titer technology, a new analytical tool designed to deliver titer measurements earlier in the cell line development process. The company says the technology gives biopharmaceutical developers faster insights during early screening stages, potentially shortening timelines for selecting high-producing cell lines in biologic drug development.
Why now: The bioprocessing industry is interested in tools that speed up cell line development and biologics production decisions.
Evidence
- Nova Biomedical introduces PAIA Titer technology for earlier cell line development insights · Select Science
API: https://socialmediatrends-api.osmike.com/v1/trends/3548121